{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:54:15Z","timestamp":1792684455380,"version":"4.5.0"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The magnitude of thyroid cancer overdiagnosis in the US, accounting for the true increase in underlying disease, has not been quantified. The implications of reducing thyroid ultrasonography use for these rates has not been calculated.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate US population-level rates of papillary thyroid cancer (PTC) overdiagnosis, and to identify the implications of reducing thyroid ultrasonography use for thyroid cancer incidence and overall mortality.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This study used a validated simulation model (Papillary Thyroid Carcinoma Microsimulation Model) of contemporary PTC incidence in the adult US population between 1991 and 2019. Data analysis was conducted from June 2024 to August 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Thyroid cancer incidence and referrals for ultrasonography of nonpalpable thyroid nodules.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Model-estimated relative and absolute rates of PTC overdiagnosis, stratified by sex. The model estimated changes in the rates of thyroid cancer incidence and overall mortality if ultrasonography rates were reduced.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The simulation included all adults, aged 18 years or older, in the US. Between 1991 and 2019, the model estimated that 72% to 94% of PTC cases were overdiagnosed. While the proportion of overdiagnosis was slightly higher for women compared with men (75%-95% vs 63%-90%), the absolute rate of overdiagnosis was higher among women compared with men (13-17 per 100\u202f000 individuals vs 3-5 per 100\u202f000 individuals). This rate translated into 443\u202f212 to 573\u202f705 women and 107\u202f804 to 154\u202f504 men who were overdiagnosed with PTC over 28 years. Reducing use of thyroid ultrasonography for nonpalpable nodules by 33% and 67% would have decreased PTC incidence by 17% (18 to 15 per 100\u202f000 individuals) and 41% (18 to 11 per 100\u202f000 individuals) in 2019, respectively, a less than 0.1% change in overall mortality.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study found that thyroid cancer overdiagnosis in the US remains substantial, even after accounting for possible increases in true incidence. This finding suggests an opportunity to reduce unnecessary thyroid ultrasonography referrals, particularly for nonpalpable nodules, and to reduce unnecessary diagnoses and treatment-related harms without increasing mortality.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.59852","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:30:18Z","timestamp":1771950618000},"page":"e2559852","source":"Crossref","is-referenced-by-count":13,"title":["Overdiagnosis of Papillary Thyroid Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"David O.","family":"Francis","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head & Neck Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"},{"name":"Wisconsin Surgical Outcomes Research Program, Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head & Neck Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"},{"name":"Wisconsin Surgical Outcomes Research Program, Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"},{"name":"Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Industrial and Systems Engineering, College of Engineering, University of Wisconsin-Madison, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Arroyo","sequence":"additional","affiliation":[{"name":"University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fernandes-Taylor","sequence":"additional","affiliation":[{"name":"Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nordby","sequence":"additional","affiliation":[{"name":"Wisconsin Surgical Outcomes Research Program, Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A. Y.","family":"Cher","sequence":"additional","affiliation":[{"name":"Wisconsin Surgical Outcomes Research Program, Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"},{"name":"Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa","family":"Venkatesh","sequence":"additional","affiliation":[{"name":"Wisconsin Surgical Outcomes Research Program, Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"Aiello Bowles","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguzhan","family":"Alagoz","sequence":"additional","affiliation":[{"name":"Department of Industrial and Systems Engineering, College of Engineering, University of Wisconsin-Madison, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"6","key":"zoi251590r1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis.","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"18","key":"zoi251590r2","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002.","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"issue":"7","key":"zoi251590r3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJM194708142370703","article-title":"The occurrence of carcinoma of the thyroid gland in autopsy material.","volume":"237","author":"Vanderlaan","year":"1947","journal-title":"N Engl J Med"},{"issue":"30","key":"zoi251590r4","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1200\/JCO.2016.67.7419","article-title":"Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis.","volume":"34","author":"Furuya-Kanamori","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10","key":"zoi251590r5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jamainternmed.2021.4804","article-title":"Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy.","volume":"181","author":"LeClair","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi251590r6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2214\/ajr.155.3.2117366","article-title":"Is earlier diagnosis really better? the misleading effects of lead time and length biases.","volume":"155","author":"Black","year":"1990","journal-title":"AJR Am J Roentgenol"},{"issue":"17","key":"zoi251590r7","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJM199304293281706","article-title":"Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.","volume":"328","author":"Black","year":"1993","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi251590r8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer.","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"zoi251590r9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1056\/NEJMe2409985","article-title":"Prostate biopsy in men with an elevated PSA level\u2014reducing overdiagnosis.","volume":"391","author":"Pinsky","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi251590r10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis.","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi251590r11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening.","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi251590r12","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMe2214658","article-title":"Reducing prostate cancer overdiagnosis.","volume":"387","author":"Gulati","year":"2022","journal-title":"N Engl J Med"},{"issue":"18","key":"zoi251590r13","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement.","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"zoi251590r14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamadermatol.2022.0139","article-title":"Estimating overdiagnosis of melanoma using trends among Black and White patients in the US.","volume":"158","author":"Adamson","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"6","key":"zoi251590r15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/bjd\/ljae296","article-title":"Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia.","volume":"191","author":"Lindsay","year":"2024","journal-title":"Br J Dermatol"},{"issue":"3","key":"zoi251590r16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/bmjebm-2023-112460","article-title":"Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method.","volume":"29","author":"Adamson","year":"2024","journal-title":"BMJ Evid Based Med"},{"issue":"1","key":"zoi251590r17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/bmjebm-2023-112341","article-title":"Overdiagnosis in malignant melanoma: a scoping review.","volume":"29","author":"Bj\u00f8rch","year":"2024","journal-title":"BMJ Evid Based Med"},{"issue":"21","key":"zoi251590r18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence.","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"zoi251590r19","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","article-title":"Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness.","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"issue":"1_suppl","key":"zoi251590r20","doi-asserted-by":"publisher","first-page":"126S","DOI":"10.1177\/0272989X17729358","article-title":"Modeling Ductal Carcinoma In Situ (DCIS): an overview of CISNET model approaches.","volume":"38","author":"van Ravesteyn","year":"2018","journal-title":"Med Decis Making"},{"issue":"9","key":"zoi251590r21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.acra.2015.05.007","article-title":"The effects of changes in utilization and technological advancements of cross-sectional imaging on radiologist workload.","volume":"22","author":"McDonald","year":"2015","journal-title":"Acad Radiol"},{"issue":"5","key":"zoi251590r22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/MED.0000000000000814","article-title":"Overuse of thyroid ultrasound.","volume":"30","author":"Acosta","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"12","key":"zoi251590r23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/thy.2015.0098","article-title":"Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American Thyroid Cancer Survivorship Study.","volume":"25","author":"Aschebrook-Kilfoy","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"zoi251590r24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.surg.2019.03.040","article-title":"Active surveillance of low-risk papillary thyroid cancer: a meta-analysis.","volume":"167","author":"Saravana-Bawan","year":"2020","journal-title":"Surgery"},{"issue":"8","key":"zoi251590r25","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1210\/clinem\/dgae082","article-title":"Nonoperative, active surveillance of larger malignant and suspicious thyroid nodules.","volume":"109","author":"Altshuler","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"zoi251590r26","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1001\/jamaoncol.2022.3875","article-title":"Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial.","volume":"8","author":"Ho","year":"2022","journal-title":"JAMA Oncol"},{"issue":"8","key":"zoi251590r27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jnci\/djz202","article-title":"Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995-2015).","volume":"112","author":"Kitahara","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi251590r28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jval.2023.12.007","article-title":"Modeling thyroid cancer epidemiology in the United States using papillary thyroid carcinoma microsimulation model.","volume":"27","author":"Alagoz","year":"2024","journal-title":"Value Health"},{"issue":"17","key":"zoi251590r29","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer.","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi251590r30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jama.2023.25881","article-title":"Analysis of breast cancer mortality in the US-1975 to 2019.","volume":"331","author":"Caswell-Jin","year":"2024","journal-title":"JAMA"},{"issue":"19","key":"zoi251590r31","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2021.5746","article-title":"Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force.","volume":"325","author":"Knudsen","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"zoi251590r32","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1001\/jama.2021.1077","article-title":"Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force.","volume":"325","author":"Meza","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"zoi251590r33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jamaoto.2024.3146","article-title":"Thyroid cancer incidence during 2020 to 2021 COVID-19 variant waves.","volume":"150","author":"Bell","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"10","key":"zoi251590r34","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance.","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"4","key":"zoi251590r35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/thy.2017.0448","article-title":"Trends in the implementation of active surveillance for low-risk papillary thyroid microcarcinomas at Kuma Hospital: gradual increase and heterogeneity in the acceptance of this new management option.","volume":"28","author":"Ito","year":"2018","journal-title":"Thyroid"},{"issue":"13","key":"zoi251590r36","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013.","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"zoi251590r37","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2213-8587(24)00223-7","article-title":"Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study.","volume":"12","author":"Li","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"zoi251590r38","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis.","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi251590r39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1089\/thy.2015.0116","article-title":"The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries.","volume":"25","author":"Vaccarella","year":"2015","journal-title":"Thyroid"},{"issue":"18","key":"zoi251590r40","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.2017.0562","article-title":"Screening for thyroid cancer: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"317","author":"Lin","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"zoi251590r41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamaoto.2022.1743","article-title":"Evaluating the rising incidence of thyroid cancer and thyroid nodule detection modes: a multinational, multi-institutional analysis.","volume":"148","author":"Sajisevi","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"zoi251590r42","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1089\/thy.2024.0344","article-title":"Differential ultrasound rates mirror sex disparities in thyroid cancer.","volume":"34","author":"Fernandes-Taylor","year":"2024","journal-title":"Thyroid"},{"issue":"1","key":"zoi251590r43","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/SLA.0000000000004417","article-title":"Barriers to the use of active surveillance for thyroid cancer results of a physician survey.","volume":"276","author":"Hughes","year":"2022","journal-title":"Ann Surg"},{"issue":"4","key":"zoi251590r44","doi-asserted-by":"publisher","first-page":"e1728","DOI":"10.1210\/clinem\/dgaa942","article-title":"Adoption of active surveillance for very low-risk differentiated thyroid cancer in the United States: a national survey.","volume":"106","author":"Pitt","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi251590r45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/M15-0969","article-title":"Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation.","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi251590r46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7326\/M15-0970","article-title":"Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force recommendation.","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi251590r47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10549-019-05167-2","article-title":"Validation of the Breast Cancer Surveillance Consortium model of breast cancer risk.","volume":"175","author":"Tice","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"28","key":"zoi251590r48","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","article-title":"Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer.","volume":"33","author":"Tice","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2845450\/francis_2026_oi_251590_1774543009.24302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:00:35Z","timestamp":1775055635000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2845450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.59852","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}